Jefferies analyst Roger Song raised the price target on Vaxcyte (NASDAQ: PCVX) to $129.00 (from $108.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE